Hepion Pharmaceuticals Inc (HEPA) — Cash Flow Quality Index

Latest as of June 2017: -2.07x

Hepion Pharmaceuticals Inc (HEPA) has a Cash Flow Quality Index of -2.07x as of June 2017. Operating cash flow of $-4.25 Million is below net income of $2.05 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Hepion Pharmaceuticals Inc generate cash to assess how effectively this company generates cash.

Cash Flow Quality Index

-2.07x
Operating CF / Net Income

Operating Cash Flow

$-4.25 Million
USD

Net Income

$2.05 Million
USD

Data as of

Jun 2017
Most recent filing

Annual Cash Flow Quality Index for Hepion Pharmaceuticals Inc (None–None)

Year-by-year earnings quality comparison for Hepion Pharmaceuticals Inc. For live market cap and the full company financial profile, see market cap of Hepion Pharmaceuticals Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.